Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
7.68
-0.09 (-1.16%)
At close: Sep 12, 2025, 4:00 PM EDT
7.65
-0.03 (-0.39%)
After-hours: Sep 12, 2025, 7:59 PM EDT
Teladoc Health Revenue
Teladoc Health had revenue of $631.90M in the quarter ending June 30, 2025, a decrease of -1.64%. This brings the company's revenue in the last twelve months to $2.54B, down -2.57% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.54B
Revenue Growth
-2.57%
P/S Ratio
0.52
Revenue / Employee
$462,231
Employees
5,500
Market Cap
1.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TDOC News
- 4 weeks ago - Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health - GlobeNewsWire
- 6 weeks ago - Teladoc Health: Still Struggling To Find A Catalyst - Seeking Alpha
- 6 weeks ago - Teladoc Health Earnings: Not Dead Yet - Seeking Alpha
- 6 weeks ago - Teladoc Health, Inc. (TDOC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Wingspan Raises $24M Series B to Scale Embedded Contractor Management and Capture $1.4T Market - PRNewsWire
- 2 months ago - Teladoc Health to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Teladoc Health Launches Wellbound Employee Assistance Program (EAP) - GlobeNewsWire
- 2 months ago - Teladoc Health: A Beaten-Down Bargain Worth A Second Look (Upgrade) - Seeking Alpha